Format

Send to

Choose Destination
Exp Clin Endocrinol Diabetes. 2019 Dec;127(S 01):S97-S101. doi: 10.1055/a-1018-9228. Epub 2019 Dec 20.

Position Paper on Lipid Therapy in Patients with Diabetes Mellitus.

Author information

1
Medical Department IV-Grosshadern, University of Munich, Munich, Germany.
2
Medical Clinic IV, University Hospital, Tübingen, Germany.
3
Institute for Diabetes Research and Metabolic Diseases (IDM) of Helmholtz Zentrum München at the Tübingen University, German Centre for Diabetes Research, Germany.
4
Polyclinic for Endocrinology, Diabetology and Preventive Medicine, University Hospital Cologne, Cologne, Germany.
5
Medical Clinic I - Cardiology, Angiology and Internal Intensive Care Medicine, University Hospital Aachen, Aachen, Germany.
6
Endocrinologikum Hamburg, Hamburg, Germany.
7
Clinic for Cardiology and Angiology I, University Heart Centre, Freiburg, Germany.
PMID:
31860929
DOI:
10.1055/a-1018-9228

Conflict of interest statement

K.G.P. received lecture fees, fees for Advisory Board activities, fees for DMC activity and/or research support from the following companies: Aegerion, Akcea, Amarin, Amgen, Berlin- Chemie, Boehringer-Ingelheim, Ionis, Lilly, MSD, Regeneron, Sanofi. A.L.B. received lecture fees from Amgen, MSD and Sanofi. W.K. received lecture fees from Amgen, Bayer Vital, Boehringer Ingelheim, OmniaMed, Roche and Sanofi. N.M. has received support from Boehringer Ingelheim to lead clinical trials, acts as a consultant to Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, MSD, NovoNordisk and Sanofi- Aventis and receives research funding from MSD and Boehringer Ingelheim. In addition, he has lectured for Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Lilly, MSD, NovoNordisk and Sanofi-Aventis. has received research funding for experimental and clinical studies from Boehringer Ingelheim and MSD; he has served as a consultant for Boehringer Ingelheim, Sanofi-Aventis, MSD, AstraZeneca, Lilly, Novo- Nordisk, Amgen and Bayer and as a speaker for Boehringer Ingelheim, Sanofi-Aventis, MSD, AstraZeneca, Lilly, NovoNordisk and Bayer. has received fees and/or research funding from Amgen, Berlin- Chemie, MSD and Sanofi.

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center